Drug Name:
SOMINEX OTC
Generic Name and Formulations:
Diphenhydramine HCl 25mg; tabs.
Company:
GlaxoSmithKline
Therapeutic Use:
Indications for SOMINEX:
Short-term (≤ 2 weeks) treatment of insomnia.
Adult:
50mg at bedtime.
Children:
Not recommended.
Warnings/Precautions:
Asthma. Lower respiratory disorders. Glaucoma. Hyperthyroidism. Hypertension. Cardiovascular disease. GI or urinary obstruction. Pregnancy. Nursing mothers.
See Also:
Pharmacological Class:
Hypnotic (anticholinergic).
Interactions:
Potentiates CNS depression with alcohol, other CNS depressants. Concomitant diphenhydramine products (including topicals): not recommended. Additive effects with other other anticholinergics.
Adverse Reactions:
Drowsiness, dizziness, anticholinergic effects, paradoxical excitement.
How Supplied:
Original (tabs)—16, 32, 72
Max Strength (caplets)—16
Clinical Pain Advisor Articles
- Notifications by PDMPs May Not Effectively Reduce Opioid Misuse
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Suprazygomatic Sphenopalatine Ganglion Block May Quickly Relieve Status Migrainosus Pain
- Electroacupuncture May Help Reduce Opioid Use in Chronic Musculoskeletal Pain
- Low Literacy Self-Management Program for Chronic Pain May Be Effective
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- The Challenge of Compassion in Modern Healthcare Settings
- Republican Opposition to Obamacare: What's Done, What's to Come
- Lowering Default Pill Counts in EMRs May Effectively Reduce Postoperative Opioid Prescription Numbers
- Steps Taken to Increase Use of Electronic Tools in Medicine
- Daily and Retrospective Pain Measurements Comparable in Hip Osteoarthritis
